Amy M Berkman1, Abenaa M Brewster2, Lee W Jones3, Jun Yu4, J Jack Lee4, S Andrew Peng4, Abigail Crocker5, Joann L Ater6, Susan C Gilchrist2. 1. 1 Larner College of Medicine, University of Vermont , Burlington, Vermont. 2. 2 Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center , Houston, Texas. 3. 3 Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, New York. 4. 4 Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center , Houston, Texas. 5. 5 Department of Mathematics and Statistics, University of Vermont , Burlington, Vermont. 6. 6 Division of Pediatrics, The University of Texas M.D. Anderson Cancer Center , Houston, Texas.
Abstract
PURPOSE: Whether cardiovascular disease (CVD) risk differs according to race and cancer type among survivors of childhood or young adulthood cancers is unknown. METHODS: Data from the years 1973-2011 were analyzed using the Surveillance, Epidemiology, and End Results (SEER) registries. Cases were categorized by ICD-0-3/WHO 2008 Adolescent and Young Adult classification. CVD death was determined by ICD-10 codes for diseases of the heart, atherosclerosis, cerebrovascular diseases, or other diseases of the arteries. Cox proportional hazards models were fitted to evaluate the hazard ratio (HR) and 95% confidence intervals (CIs) for the effects of race on time-to-event outcomes. RESULTS: A total of 164,316 cases of childhood and young adult primary cancers were identified. There were 43,335 total and 1466 CVD deaths among Black and White survivors. Black survivors had higher risks of all-cause mortality (HR: 1.75, 95% CI: 1.70-1.7) and CVD mortality (HR: 2.13, 95% CI: 1.85-2.46) compared to White survivors. The increased risk of CVD for Black survivors compared to White survivors persisted at 5-years (HR: 2.38, 95% CI: 1.83-3.10), 10-years (HR: 2.59, 95% CI: 2.09-3.21), and 20-years (HR: 2.31, 95% CI: 1.95-2.74) postdiagnosis, and varied by cancer type, with the highest HRs for melanoma (HR: 8.16, 95% CI: 1.99-33.45) and thyroid cancer (HR: 3.43, 95% CI: 1.75-6.73). CONCLUSIONS: Black survivors of childhood or young adulthood cancers have a higher risk of CVD mortality compared to Whites that varies by cancer type. Knowledge of at-risk populations is important to guide surveillance recommendations and behavioral interventions. Further study is needed to understand the etiology of racial differences in CVD mortality in this population.
PURPOSE: Whether cardiovascular disease (CVD) risk differs according to race and cancer type among survivors of childhood or young adulthood cancers is unknown. METHODS: Data from the years 1973-2011 were analyzed using the Surveillance, Epidemiology, and End Results (SEER) registries. Cases were categorized by ICD-0-3/WHO 2008 Adolescent and Young Adult classification. CVD death was determined by ICD-10 codes for diseases of the heart, atherosclerosis, cerebrovascular diseases, or other diseases of the arteries. Cox proportional hazards models were fitted to evaluate the hazard ratio (HR) and 95% confidence intervals (CIs) for the effects of race on time-to-event outcomes. RESULTS: A total of 164,316 cases of childhood and young adult primary cancers were identified. There were 43,335 total and 1466 CVD deaths among Black and White survivors. Black survivors had higher risks of all-cause mortality (HR: 1.75, 95% CI: 1.70-1.7) and CVD mortality (HR: 2.13, 95% CI: 1.85-2.46) compared to White survivors. The increased risk of CVD for Black survivors compared to White survivors persisted at 5-years (HR: 2.38, 95% CI: 1.83-3.10), 10-years (HR: 2.59, 95% CI: 2.09-3.21), and 20-years (HR: 2.31, 95% CI: 1.95-2.74) postdiagnosis, and varied by cancer type, with the highest HRs for melanoma (HR: 8.16, 95% CI: 1.99-33.45) and thyroid cancer (HR: 3.43, 95% CI: 1.75-6.73). CONCLUSIONS: Black survivors of childhood or young adulthood cancers have a higher risk of CVD mortality compared to Whites that varies by cancer type. Knowledge of at-risk populations is important to guide surveillance recommendations and behavioral interventions. Further study is needed to understand the etiology of racial differences in CVD mortality in this population.
Authors: Liisa S Järvelä; Jukka Kemppainen; Harri Niinikoski; Jarna C Hannukainen; Päivi M Lähteenmäki; Jukka Kapanen; Mikko Arola; Olli J Heinonen Journal: Pediatr Blood Cancer Date: 2011-12-19 Impact factor: 3.167
Authors: Steven E Lipshultz; Nader Rifai; Virginia M Dalton; Donna E Levy; Lewis B Silverman; Stuart R Lipsitz; Steven D Colan; Barbara L Asselin; Ronald D Barr; Luis A Clavell; Craig A Hurwitz; Albert Moghrabi; Yvan Samson; Marshall A Schorin; Richard D Gelber; Stephen E Sallan Journal: N Engl J Med Date: 2004-07-08 Impact factor: 91.245
Authors: Georita M Frierson; David M Williams; Shira Dunsiger; Beth A Lewis; Jessica A Whiteley; Anna E Albrecht; John M Jakicic; Santina M Horowitz; Bess H Marcus Journal: Clin Trials Date: 2008 Impact factor: 2.486
Authors: E Anne Lown; Nobuko Hijiya; Nan Zhang; Deo Kumar Srivastava; Wendy M Leisenring; Paul C Nathan; Sharon M Castellino; Katie A Devine; Kimberley Dilley; Kevin R Krull; Kevin C Oeffinger; Melissa M Hudson; Gregory T Armstrong; Leslie L Robison; Kirsten K Ness Journal: Cancer Date: 2016-06-03 Impact factor: 6.860
Authors: Theresa H M Keegan; Lawrence H Kushi; Qian Li; Ann Brunson; X Chawla; Helen K Chew; Marcio Malogolowkin; Ted Wun Journal: J Cancer Surviv Date: 2018-02-09 Impact factor: 4.442
Authors: Chelsea Anderson; Jennifer L Lund; Mark A Weaver; William A Wood; Andrew F Olshan; Hazel B Nichols Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-06-17 Impact factor: 4.254
Authors: Amy M Berkman; Clark R Andersen; Vidya Puthenpura; J A Livingston; Sairah Ahmed; Branko Cuglievan; Michelle A T Hildebrandt; Michael E Roth Journal: Cancer Epidemiol Date: 2021-09-28 Impact factor: 2.984
Authors: Jason F Goldberg; Kirsten K Ness; Xiaofei Chi; Aimee K Santucci; Juan Carlos Plana; Vijaya M Joshi; Russell V Luepker; Jean-Bernard Durand; Robyn E Partin; Rebecca M Howell; Carmen L Wilson; Jeffrey A Towbin; John L Jefferies; Deo Kumar Srivastava; Melissa M Hudson; Leslie L Robison; Gregory T Armstrong Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-10-08 Impact factor: 4.090
Authors: Daniel A Mulrooney; Yutaka Yasui; Yadav Sapkota; Na Qin; Matthew J Ehrhardt; Zhaoming Wang; Yan Chen; Carmen L Wilson; Jeremie Estepp; Parul Rai; Jane S Hankins; Paul W Burridge; John L Jefferies; Jinghui Zhang; Melissa M Hudson; Leslie L Robison; Gregory T Armstrong Journal: Cancer Res Date: 2020-12-07 Impact factor: 13.312
Authors: Tegan J Reeves; Taylor J Mathis; Hailey E Bauer; Melissa M Hudson; Leslie L Robison; Zhaoming Wang; Justin N Baker; I-Chan Huang Journal: Front Public Health Date: 2021-10-29
Authors: Amy M Berkman; Clark R Andersen; Vidya Puthenpura; J Andrew Livingston; Sairah Ahmed; Branko Cuglievan; Michelle A T Hildebrandt; Michael E Roth Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-07-08 Impact factor: 4.254